SwePub
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "AMNE:(MEDICIN OCH HÄLSOVETENSKAP) "

Sökning: AMNE:(MEDICIN OCH HÄLSOVETENSKAP)

  • Resultat 238481-238490 av 252469
Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
238481.
  • Borde, A. S., et al. (författare)
  • Assessment of enzymatic prodrug stability in human, dog and simulated intestinal fluids
  • 2012
  • Ingår i: European journal of pharmaceutics and biopharmaceutics. - : Elsevier BV. - 0939-6411 .- 1873-3441. ; 80:3, s. 630-637
  • Tidskriftsartikel (refereegranskat)abstract
    • The aim of this study was to determine the stability of three ester prodrugs, chloramphenicol succinate, enalapril and candesartan cilexetil, in human proximal small intestinal fluid (HIF), dog proximal small intestinal fluids (DIF) and simulated intestinal fluid (FaSSIF), with the addition of pancreatin. The total protein content in the proximal jejuna] fluids was determined in HIF and DIF, respectively. Candesartan cilexetil was significantly degraded in HIF (initial t(1/2(0-5min)) 5.4 +/- 0.5 min) and in DIF (initial t(1/2(0-5min))) = 5.7 +/- 0.1 min), while chloramphenicol succinate and enalapril were stable in both media. The degradation of candesartan cilexetil was shown to be mediated by enzymes following Michaelis-Menten enzyme kinetics and was inhibited by addition of esterase inhibitors. The enzymatic capacity reflected by V-max was 4-fold higher in DIF than in HIF and correlated to its 2-fold higher protein concentration. The degradation of candesartan cilexetil in the FaSSIF-pancreatin solution was slower (t(1/2) = 207 +/- 34 min) than the degradation in both HIF and DIF. Changing the pH to the enzyme optima or increasing the amount of pancreatin, increased the degradation rate of candesartan cilexetil, but not in the magnitude as in HIF. As a result, two in vitro models, based on in vivo intestinal fluids, were developed using candesartan cilexetil as a model drug. The DIF seems to be a reasonably good model for HIF, although the degradation capacity seems to be somewhat higher, possibly due to the higher enzyme concentration in DIF. Future investigations will develop novel enzymatic based in vitro models for rapid assessment and biopharmaceutical screening tools for prodrugs.
  •  
238482.
  •  
238483.
  •  
238484.
  •  
238485.
  •  
238486.
  • Borg, Åke, et al. (författare)
  • Characterization of BRCA1 and BRCA2 deleterious mutations and variants of unknown clinical significance in unilateral and bilateral breast cancer: the WECARE study.
  • 2010
  • Ingår i: Human Mutation. - : Hindawi Limited. - 1059-7794 .- 1098-1004. ; 31, s. 1200-1240
  • Tidskriftsartikel (refereegranskat)abstract
    • BRCA1 and BRCA2 screening in women at high-risk of breast cancer results in the identification of both unambiguously defined deleterious mutations and sequence variants of unknown clinical significance (VUS). We examined a population-based sample of young women with contralateral breast cancer (CBC, n=705) or unilateral breast cancer (UBC, n=1398). We identified 470 unique sequence variants, of which 113 were deleterious mutations. The remaining 357 VUS comprised 185 unique missense changes, 60% were observed only once, while 3% occurred with a frequency of >10%. Deleterious mutations occurred three times more often in women with CBC (15.3%) than in women with UBC (5.2%), whereas combined, VUS were observed in similar frequencies in women with CBC and UBC. A protein alignment algorithm defined 16 rare VUS, occurring at highly conserved residues and/or conferring a considerable biochemical difference, the majority located in the BRCA2 DNA-binding domain. We confirm a multiplicity of BRCA1 and BRCA2 VUS that occur at a wide range of allele frequencies. Although some VUS inflict chemical differences at conserved residues, suggesting a deleterious effect, the majority are not associated with an increased risk of CBC. (c) 2010 Wiley-Liss, Inc.
  •  
238487.
  •  
238488.
  • Borhade, Sanjay R, et al. (författare)
  • Inhibition of Insulin-Regulated Aminopeptidase (IRAP) by Arylsulfonamides
  • 2014
  • Ingår i: ChemistryOpen. - : Wiley. - 2191-1363. ; 3:6, s. 256-263
  • Tidskriftsartikel (refereegranskat)abstract
    • The inhibition of insulin-regulated aminopeptidase (IRAP, EC 3.4.11.3) by angiotenesin IV is known to improve memory and learning in rats. Screening 10 500 low-molecular-weight compounds in an enzyme inhibition assay with IRAP from Chinese Hamster Ovary (CHO) cells provided an arylsulfonamide (N-(3-(1H-tetrazol-5-yl)phenyl)-4-bromo-5-chlorothiophene-2-sulfonamide), comprising a tetrazole in the meta position of the aromatic ring, as a hit. Analogues of this hit were synthesized, and their inhibitory capacities were determined. A small structure-activity relationship study revealed that the sulfonamide function and the tetrazole ring are crucial for IRAP inhibition. The inhibitors exhibited a moderate inhibitory potency with an IC50=1.1±0.5 μm for the best inhibitor in the series. Further optimization of this new class of IRAP inhibitors is required to make them attractive as research tools and as potential cognitive enhancers.
  •  
238489.
  • Bornscheuer, Lisa, 1990-, et al. (författare)
  • Functional Variation in the FAAH Gene Is Directly Associated with Subjective Well-Being and Indirectly Associated with Problematic Alcohol Use
  • 2023
  • Ingår i: Genes. - 2073-4425. ; 14:9
  • Tidskriftsartikel (refereegranskat)abstract
    • Fatty acid amide hydrolase (FAAH) is an enzyme that degrades anandamide, an endocannabinoid that modulates mesolimbic dopamine release and, consequently, influences states of well-being. Despite these known interactions, the specific role of FAAH in subjective well-being remains underexplored. Since well-being is a dynamic trait that can fluctuate over time, we hypothesized that we could provide deeper insights into the link between FAAH and well-being using longitudinal data. To this end, we analyzed well-being data collected three years apart using the WHO (Ten) Well-Being Index and genotyped a functional polymorphism in the FAAH gene (rs324420, Pro129Thr) in a sample of 2822 individuals. We found that the A-allele of rs324420, which results in reduced FAAH activity and elevated anandamide levels, was associated with lower well-being scores at both time points (Wave I, B: −0.52, p = 0.007; Wave II, B: −0.41, p = 0.03, adjusted for age and sex). A subsequent phenome-wide association study (PheWAS) affirmed our well-being findings in the UK Biobank (N = 126,132, alternative C-allele associated with elevated happiness, p = 0.008) and revealed an additional association with alcohol dependence. In our cohort, using lagged longitudinal mediation analyses, we uncovered evidence of an indirect association between rs324420 and problematic alcohol use (AUDIT-P) through the pathway of lower well-being (indirect effect Boot: 0.015, 95% CI [0.003, 0.030], adjusted for AUDIT in Wave I). We propose that chronically elevated anandamide levels might influence disruptions in the endocannabinoid system—a biological contributor to well-being—which could, in turn, contribute to increased alcohol intake, though multiple factors may be at play. Further genetic studies and mediation analyses are needed to validate and extend these findings.
  •  
238490.
  • Borrebaeck, Carl, et al. (författare)
  • Progress in miniaturisation of proteon arrays - a step closer to high-density nanoarrays
  • 2007
  • Ingår i: Drug Discovery Today. - : Elsevier BV. - 1878-5832 .- 1359-6446. ; 12:19-20, s. 813-819
  • Forskningsöversikt (refereegranskat)abstract
    • Protein microarrays is a technology with great promise for high-throughput proteomics. Designing high-performance protein microarrays for global proteome analysis has, however, turned out to be challenging. To this end, major efforts are under way to design novel array formats capable of harboring the tremendous range of probes required to target complex proteomes composed of more than 10 000 analytes. By adopting nanotechnology, the first generation of miniaturized nanoarrays has recently emerged, which opens up new avenues for global proteome analysis and disease proteomics. This review describes the progress and key issues in designing miniaturized protein arrays.
  •  
Skapa referenser, mejla, bekava och länka
  • Resultat 238481-238490 av 252469
Typ av publikation
tidskriftsartikel (193710)
konferensbidrag (18357)
doktorsavhandling (12701)
forskningsöversikt (10043)
bokkapitel (7618)
annan publikation (4412)
visa fler...
rapport (2895)
bok (1033)
samlingsverk (redaktörskap) (684)
licentiatavhandling (456)
recension (352)
patent (112)
proceedings (redaktörskap) (79)
konstnärligt arbete (46)
visa färre...
Typ av innehåll
refereegranskat (203735)
övrigt vetenskapligt/konstnärligt (44943)
populärvet., debatt m.m. (3754)
Författare/redaktör
Zetterberg, Henrik, ... (2079)
Blennow, Kaj, 1958 (1783)
Sundquist, Kristina (856)
Sundquist, Jan (815)
Nilsson, Peter (780)
Melander, Olle (750)
visa fler...
Larsson, Anders (700)
Iwarsson, Susanne (680)
Gillberg, Christophe ... (656)
Groop, Leif (653)
Lind, Lars (626)
Lundälv, Jörgen, 196 ... (611)
Hansson, Oskar (579)
Janson, Christer (576)
Larsson, Henrik, 197 ... (559)
Ohlsson, Claes, 1965 (558)
Riboli, Elio (554)
Tumino, Rosario (549)
Engström, Gunnar (537)
Overvad, Kim (521)
Lissner, Lauren, 195 ... (498)
Trichopoulou, Antoni ... (485)
Erlinge, David (485)
Kaaks, Rudolf (481)
Boeing, Heiner (480)
Rosengren, Annika, 1 ... (479)
Wolk, Alicja (470)
Stibrant Sunnerhagen ... (446)
Moons, Philip, 1968 (443)
Swedberg, Karl, 1944 (442)
Fridlund, Bengt (439)
Ludvigsson, Jonas F. ... (428)
Hemminki, Kari (427)
Wennergren, Göran, 1 ... (426)
Olsson, Håkan (425)
Skoog, Ingmar, 1954 (423)
Stattin, Pär (416)
Khaw, Kay-Tee (413)
Palli, Domenico (413)
Weiderpass, Elisabet ... (412)
Karlsson, Jón, 1953 (408)
Bruze, Magnus (397)
Andersson, Roland (386)
Edvinsson, Lars (377)
Lichtenstein, Paul (374)
Herlitz, Johan, 1949 (369)
Borg, Åke (367)
Simrén, Magnus, 1966 (361)
Manjer, Jonas (360)
Larsson, Susanna C. (358)
visa färre...
Lärosäte
Lunds universitet (69767)
Göteborgs universitet (56079)
Uppsala universitet (45403)
Karolinska Institutet (40248)
Umeå universitet (28669)
Linköpings universitet (19740)
visa fler...
Örebro universitet (15418)
Stockholms universitet (8299)
Kungliga Tekniska Högskolan (6022)
Linnéuniversitetet (5051)
Jönköping University (4980)
Malmö universitet (4843)
Chalmers tekniska högskola (4839)
Mittuniversitetet (3799)
Karlstads universitet (3516)
Luleå tekniska universitet (3007)
Mälardalens universitet (2933)
Högskolan Dalarna (2907)
Sveriges Lantbruksuniversitet (2631)
Högskolan i Halmstad (2519)
Högskolan i Gävle (2363)
Gymnastik- och idrottshögskolan (2271)
Högskolan i Borås (2076)
Högskolan i Skövde (1918)
Högskolan Kristianstad (1780)
Marie Cederschiöld högskola (1688)
Högskolan Väst (1473)
Sophiahemmet Högskola (1120)
Röda Korsets Högskola (1096)
Blekinge Tekniska Högskola (768)
RISE (612)
Södertörns högskola (502)
Handelshögskolan i Stockholm (424)
VTI - Statens väg- och transportforskningsinstitut (350)
Försvarshögskolan (62)
IVL Svenska Miljöinstitutet (25)
Naturvårdsverket (23)
Naturhistoriska riksmuseet (22)
Nordiska Afrikainstitutet (19)
Kungl. Musikhögskolan (15)
Konstfack (10)
Enskilda Högskolan Stockholm (7)
Stockholms konstnärliga högskola (5)
Riksantikvarieämbetet (2)
Havs- och vattenmyndigheten (1)
visa färre...
Språk
Engelska (234680)
Svenska (16593)
Tyska (247)
Danska (158)
Norska (152)
Spanska (122)
visa fler...
Finska (106)
Franska (75)
Odefinierat språk (54)
Italienska (39)
Ungerska (37)
Kinesiska (37)
Portugisiska (30)
Isländska (19)
Ryska (18)
Japanska (18)
Nederländska (16)
Polska (11)
Nygrekiska (9)
Tjeckiska (8)
Rumänska (7)
Latin (5)
Estniska (5)
Arabiska (4)
Koreanska (2)
Esperanto (2)
Bosniska (2)
Grekiska, klassisk (1)
Lettiska (1)
Bulgariska (1)
Persiska (1)
Kroatiska (1)
Turkiska (1)
Ukrainska (1)
Slovenska (1)
Somaliska (1)
Annat språk (1)
visa färre...
Forskningsämne (UKÄ/SCB)
Medicin och hälsovetenskap (252382)
Samhällsvetenskap (12928)
Naturvetenskap (10644)
Teknik (4211)
Humaniora (2228)
Lantbruksvetenskap (1474)

År

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy